BWIN vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

BWIN

39.7
AI Score
VS
ASTH Wins

ASTH

46.8
AI Score

Investment Advisor Scores

BWIN

40score
Recommendation
SELL

ASTH

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BWIN ASTH Winner
Revenue 1.94B 1.03B ASTH
Net Income 34.17M -36.65M ASTH
Net Margin 1.8% -3.6% ASTH
Operating Income 62.85M -109.61M ASTH
ROE 4.1% -4.1% ASTH
ROA 1.5% -0.6% ASTH
Total Assets 2.28B 6.17B BWIN
Cash 400.79M 184.50M ASTH
Current Ratio 1.23 1.07 ASTH

Relative Price Performance (Last 90 Days)

BWIN 1M: +23.2% · 3M: +56.6% ASTH 1M: -4.0% · 3M: +5.3%

Current Technical Phase

BWIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.4% over 20 days), RSI 66

RSI (14): 65.6 · Price: $31.90

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $39.35

Fundamentals Snapshot

Metric BWIN ASTH
Market Cap
Forward P/E 12.8 11.1
Trailing P/E 47.8
Revenue (TTM)
Revenue Growth 0.3% 0.5%
Gross Margin 0.3% 0.1%
Operating Margin 0.0% 0.0%
EPS -1.06 0.81
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.